Medical Portfolio Podcast

Junta-te a nós na discussão dos seguintes artigos com maior impacto clínico do mês:
#1 Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failurehttps://www.jacc.org/doi/10.1016/j.jacc.2026.07.047

#2 Continuous Glucose Monitoring in Non–Insulin-Treated Type 2 Diabeteshttps://www.nejm.org/doi/full/10.1056/NEJMoa2608571

#3 Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtvhttps://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.125.013822

Equipa científica: Ricardo Ladeiras Lopes, Mário Santos e João Sérgio Neves.  
⁠⁠www.medicalportfolio.pt

Junta-te a nós na discussão dos seguintes artigos com maior impacto clínico do mês:
 
#1 Prasugrel versus Ticagrelor in Acute Coronary Syndromes
⁠https://www.nejm.org/doi/abs/10.1056/NEJMoa2609057⁠

#2 Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults
⁠https://www.nejm.org/doi/10.1056/NEJMoa2607314⁠

#3 Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
⁠https://www.nejm.org/doi/abs/10.1056/NEJMoa2607978⁠
 

Equipa científica: Ricardo Ladeiras Lopes, Mário Santos e João Sérgio Neves.  
⁠www.medicalportfolio.pt

Junta-te a nós na discussão dos seguintes artigos com maior impacto clínico do mês:
 
#1 Complete Revascularization Guided by Functional Coronary Angiography in STEMI
https://www.nejm.org/doi/full/10.1056/NEJMoa2605373
 
#2 Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
https://www.nejm.org/doi/abs/10.1056/NEJMoa2608012
 
3# Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
https://www.nejm.org/doi/10.1056/NEJMoa2604169
 

Equipa científica: Ricardo Ladeiras Lopes, Mário Santos e João Sérgio Neves.  
www.medicalportfolio.pt

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks.

This month we’re discussing:
#1 - Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical TrialDOI: https://doi.org/10.1093/eurheartj/ehaf724

#2 - Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
DOI: 10.1056/NEJMoa2509688

#3 - Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
DOI: 10.1016/S0140-6736(25)02155-5

Scientific team:Ricardo Ladeiras Lopes, Mário Santos and João Sérgio Neves

Discover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/medicalportfolioapp⁠⁠

Join our scientific team in the discussion of the 3 most clinically impactful papers of the month, the crème de la crème of our weekly top picks. This month we’re discussing:Left bundle branch area pacing vs right ventricular pacing in preserved or mildly reduced ejection fraction: the PACE-HF trialDOI: https://doi.org/10.1093/eurheartj/ehaf724Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialDOI: https://doi.org/10.1016/S0140-6736(25)01375-3An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical TrialDOI: https://doi.org/10.1001/jama.2025.19563Scientific team:Ricardo Ladeiras Lopes, Mário Santos and João Sérgio NevesDiscover Medical Portfolio App weekly top picks - the latest and most relevant papers, curated by our team of experts! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/medicalportfolioapp⁠⁠